Deferoxamine Mesylate
Overview
Deferoxamine Mesylate is a chelating agent used to remove excess iron from the body in conditions of chronic iron overload, such as thalassemia or secondary hemochromatosis. It forms a stable complex with iron, which is then excreted from the body, thus reducing iron concentration.
API suppliers (4)
Suppliers of Deferoxamine Mesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
- EXCELLA GMBH AND CO KGGermany1 active DMF
- TAPI NL BVNetherlands1 active DMF
- Pharmacia And Upjohn
- MYTHEN SPAFrance
Therapeutic areas
Do you supply Deferoxamine Mesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.